The 2010 Investment U Conference is underway! And even if you couldn't make it, now you can "bring home" more than 30 breakthrough presentations from the conference... Order the Deluxe MP3/Video Library for $99 to listen and view on your computer, or the Premier CD plus MP3/Video Library for $149 to listen to and view anywhere.
Dow 10,000: Buy it, Or Sell it?
by Robert Williams, Publisher
Monday, October 19, 2009
Analysts expect earnings for S&P 500 companies to decline by nearly 25% from a year ago. When viewed through such a lens, the financial crisis and subsequent recession erased a quarter’s worth of profits from America’s best companies.
So how is it that the Dow Jones Industrial Average – which just poked its nose above the 10,000 level – can race higher nearly everyday? (The Dow has posted gains in roughly two-thirds of the trading days since July.)
Because we gauge companies based on their performance versus analysts’ estimates. And not by their performance relative to prior (actual) results.
It’s kind of counterintuitive, I know. But the stock market is the preeminent
forward-looking entity.
So if you want to know what’s really powering the Dow, it’s likely the fact that analysts now project S&P 500 companies to earn $75.61 a share, representing a 25% bump to their original estimates of $59.95 made just weeks ago.
Renowned economist Mark Skousen believes that Dow 10,000 could be a weigh station to 11,000 by the end of the year. And the longer-term outlook is even more bullish, to say the least.
Read Mark’s article on the Dow cracking 10,000 to see just how high he thinks it can go…
Ahead of the tape,
Robert Williams
- Biotech Stocks: The Market’s Best Bargain Right Now…
- What’s the “Fair Price” of Gold?
- The United States is the New Tanzania? Ugh…
|
The Company Set to Dominate a $60 Billion-a-Year Market
$60 billion is spent on cancer treatment in the U.S. - each year. And one company is poised to receive the lion's share of it.
The medical director at the Alta Bates Comprehensive Cancer Center says, "...possibly a third of our cancer patient population will soon be undergoing this [company's] treatment."
Another doctor at the University of Texas MD Anderson Cancer Center says he intends to treat over 1,000 patients a year with this technology.
Here's how you can claim your stake in the company before this cash infusion sends shares soaring.
One Response to “Dow 10,000: Buy it, Or Sell it?”
Comments
**By submitting your comment you agree to adhere to our Comment Policy and Privacy Policy.Check out our selection of daily Investment Research:
![]() |
![]() |












In addition to once being a full-time trader of equities and equity derivatives, Robert Williams has served as the lead financial analyst for a Forbes top-50 private corporation and an analyst for the endowment of a major academic institution. He's also been profiled in such books as Trade with Passion and Purpose and Alexander Green's The Secret of Shelter Island.
Investment U RSS Feed
October 20th, 2009 at 4:31 pm
MediaCurves.com conducted a study among 385 viewers of a news clip featuring the Dow Jones Industrial topping 10,000. Results showed that more than half of viewers (57%) reported that the national economy is improving. Despite reports of the improved economic conditions, the majority of viewers (68%) who indicated that the economy was improving also stated that they do not plan to increase their spending. In addition, 42% of the viewers reported that they are currently searching for a job.
More in depth results can be seen at:
http://www.mediacurves.com/Culture/J7600-USEconomy/Index.cfm
Thanks,
Ben
Reply